BioCentury
ARTICLE | Company News

Management tracks

November 3, 2015 1:15 AM UTC

Biosimilar company Therapeutic Proteins International LLC (Chicago, Ill.) named Peter Moesta CEO. Moesta was SVP of biologics development and operations at Bristol-Myers Squibb Co. (NYSE:BMY).

Diagnostic play Exosome Diagnostics Inc. (Cambridge, Mass.) named John Boyce CEO. He was CEO at GnuBIO Inc., which Bio-Rad Laboratories Inc. (NYSE:BIO) acquired. ...